Suppr超能文献

鉴定和实验验证 G 蛋白α抑制活性多肽 2(GNAI2)作为舌鳞癌细胞中 microRNA-138 的靶标。

Identification and experimental validation of G protein alpha inhibiting activity polypeptide 2 (GNAI2) as a microRNA-138 target in tongue squamous cell carcinoma.

机构信息

Center for Molecular Biology of Oral Diseases, College of Dentistry, University of Illinois at Chicago, 801 S. Paulina Street, Room 530C, Chicago, IL 60612, USA.

出版信息

Hum Genet. 2011 Feb;129(2):189-97. doi: 10.1007/s00439-010-0915-3. Epub 2010 Nov 16.

Abstract

MicroRNA deregulation is a critical event in tumor initiation and progression. The down-regulation of microRNA-138 has been frequently observed in various cancers, including tongue squamous cell carcinoma (TSCC). Our previous studies suggest that deregulation of miR-138 is associated with the enhanced proliferation and invasion in TSCC cells. Here, we seek to identify the targets of miR-138 in TSCC, and explore their functional relevance in tumorigenesis. Our genome-wide expression profiling experiments identified a panel of 194 unique transcripts that were significantly down-regulated in TSCC cells transfected with miR-138. A comprehensive screening using six different sequence-based microRNA target prediction algorithms revealed that 51 out of these 194 down-regulated transcripts are potential direct targets for miR-138. These targets include: chloride channel, nucleotide-sensitive, 1A (CLNS1A), G protein alpha inhibiting activity polypeptide 2 (GNAI2), solute carrier family 20, member 1 (SLC20A1), eukaryotic translation initiation factor 4E binding protein 1 (EIF4EBP1), and Rho-related GTP-binding protein C (RhoC). GNAI2 is a known proto-oncogene that is involved in the initiation and progression of several different types of tumors. Direct targeting of miR-138 to two candidate binding sequences located in the 3'-untranslated region of GNAI2 mRNA was confirmed using luciferase reporter gene assays. Knockdown of miR-138 in TSCC cells enhanced the expression of GNAI2 at both mRNA and protein levels. In contrast, ectopic transfection of miR-138 reduced the expression of GNAI2, which, in consequence, led to reduced proliferation, cell cycle arrest and apoptosis. In summary, we identified a number of high-confident miR-138 target genes, including proto-oncogene GNAI2, which may play an important role in TSCC initiation and progression.

摘要

microRNA 失调是肿瘤发生和发展的关键事件。miR-138 的下调在各种癌症中经常被观察到,包括舌鳞状细胞癌 (TSCC)。我们之前的研究表明,miR-138 的失调与 TSCC 细胞的增殖和侵袭增强有关。在这里,我们试图确定 miR-138 在 TSCC 中的靶标,并探讨它们在肿瘤发生中的功能相关性。我们的全基因组表达谱实验鉴定了一组 194 个独特的转录本,这些转录本在转染 miR-138 的 TSCC 细胞中显著下调。使用六种不同的基于序列的 microRNA 靶标预测算法进行全面筛选,发现这 194 个下调转录本中有 51 个是 miR-138 的潜在直接靶标。这些靶标包括:氯离子通道、核苷酸敏感、1A(CLNS1A)、G 蛋白α抑制活性多肽 2(GNAI2)、溶质载体家族 20 成员 1(SLC20A1)、真核翻译起始因子 4E 结合蛋白 1(EIF4EBP1)和 Rho 相关 GTP 结合蛋白 C(RhoC)。GNAI2 是一种已知的原癌基因,参与多种类型肿瘤的发生和发展。使用荧光素酶报告基因检测证实了 miR-138 直接靶向位于 GNAI2 mRNA 3'-非翻译区的两个候选结合序列。在 TSCC 细胞中敲低 miR-138 会增强 GNAI2 的 mRNA 和蛋白水平表达。相反,外源性转染 miR-138 会降低 GNAI2 的表达,从而导致增殖减少、细胞周期停滞和凋亡。总之,我们鉴定了一些高置信度的 miR-138 靶基因,包括原癌基因 GNAI2,它可能在 TSCC 的发生和发展中起重要作用。

相似文献

引用本文的文献

本文引用的文献

4
miR-138 might reverse multidrug resistance of leukemia cells.miR-138 可能逆转白血病细胞的多药耐药性。
Leuk Res. 2010 Aug;34(8):1078-82. doi: 10.1016/j.leukres.2009.10.002. Epub 2009 Nov 6.
5
MicroRNA profiling and head and neck cancer.微小RNA分析与头颈癌
Comp Funct Genomics. 2009;2009:837514. doi: 10.1155/2009/837514. Epub 2009 Jun 1.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验